| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |